Orion
56,72
EUR
-0,25 %
13.944 følger denne virksomhed
ORNBV
NASDAQ Helsinki
Biotechnology & Pharmaceuticals
Health Care
Overview
Finansielt overblik og estimater
-0,25%
+9,16%
+32,59%
+33,65%
+20,6%
+62,99%
+40,33%
+74,47%
+405,08%
Orion operates in the pharmaceutical industry. The company conducts research and development of human and veterinary drugs, where the main focus is on diseases that affect the nervous system, as well as oncology and respiratory diseases. Today, the company's products are found on a global level, with the largest presence in the Nordic region and the rest of Europe. The company's head office is located in Espoo, Finland.
Læs mereMarkedsværdi
8,01 mia. EUR
Aktieomsætning
1,49 mio. EUR
P/E (adj.) (25e)
24,27
EV/EBIT (adj.) (25e)
19,03
P/B (25e)
7,23
EV/S (25e)
4,91
Udbytteafkast, % (25e)
3 %
Omsætning og EBIT-margin
Omsætning mia.
EBIT-% (adj.)
EPS og udbytte
EPS (adj.)
Udbytte %
Finanskalender
3.4
2025
Generalforsamling '25
4.4
2025
Halvårligt udbytte
23.4
2025
Delårsrapport Q1'25
Risiko
Business risk
Valuation risk
Lav
Høj
Alle
Analyse
Selskabspræsentationer
Selskabsmeddelelser
ViserAlle indholdstyper
Pharmaceutical industry delivers value proposition to Finnish Government: billions to be invested by 2030
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools